Monday, June 22, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 536 of 1,261

  1. US 10111957

    Inhalation compositions comprising glucose anhydrous

    ARVEN ILAC SANAYI VE TICARET A.S. · Granted Oct 30, 2018 · Expires Oct 25, 2038

    granted

  2. US 10111953

    Methods for reducing remnant cholesterol and other lipoprotein fractions by administering an inhibitor of proprotein convertase subtilisin kexin-9 (PCSK9)

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 30, 2018 · Expires Oct 25, 2038

    granted

  3. US 10112900

    Modified amino acids

    Sutro Biopharma, Inc. · Granted Oct 30, 2018 · Expires Oct 25, 2038

    granted

  4. US 10113207

    Methods and compositions for targeted single-stranded cleavage and targeted integration

    Sangamo Therapeutics, Inc. · Granted Oct 30, 2018 · Expires Oct 25, 2038

    granted

  5. US 10111847

    Compounds and methods for modulating vascular injury

    The Regents of the University of California · Granted Oct 30, 2018 · Expires Oct 25, 2038

    granted

  6. US 10112917

    Therapeutic compounds

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Oct 30, 2018 · Expires Oct 25, 2038

    granted

  7. US 10111923

    Compositions comprising Cyclocarya paliurus extract and preparation method and uses thereof

    INFINITUS (CHINA) COMPANY LTD. · Granted Oct 30, 2018 · Expires Oct 25, 2038

    granted

  8. US 10111937

    Method of reducing accumulation of intracellular tingible body macrophages

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Oct 30, 2018 · Expires Oct 25, 2038

    granted

  9. US 10111878

    N,6-bis(aryl or heteroaryl)-1,3,5-triazine-2,4-diamine compounds as IDH2 mutants inhibitors for the treatment of cancer

    Agios Pharmaceuticals, Inc. · Granted Oct 30, 2018 · Expires Oct 25, 2038

    granted

  10. US 10111926

    Selectively targeted antimicrobial peptides and the use thereof

    The Regents of the University of California · Granted Oct 30, 2018 · Expires Oct 25, 2038

    granted

  11. US 10111925

    Formulations comprising plant extracts

    MONTERO GIDA SANAYI VE TICARET A.S. · Granted Oct 30, 2018 · Expires Oct 25, 2038

    granted

  12. US 10111927

    Pseudomonas exotoxin A with less immunogenic B cell epitopes

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 30, 2018 · Expires Oct 25, 2038

    granted

  13. US 10111861

    Treatment of breast cancer

    The Regents of the University of Colorado, a Body Corporate · Granted Oct 30, 2018 · Expires Oct 25, 2038

    granted

  14. US 10111810

    Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom

    Aquestive Therapeutics, Inc. · Granted Oct 30, 2018 · Expires Oct 25, 2038

    granted

  15. US 10111862

    Traps in the treatment of macular degeneration

    Aldeyra Therapeutics, Inc. · Granted Oct 30, 2018 · Expires Oct 25, 2038

    granted

  16. US 10114019

    Bacterial challenge model in cattle using a trans- and intra-dermal route to infect peripheral lymph nodes

    The United States of America, as represented by the Secretary of Agriculture · Granted Oct 30, 2018 · Expires Oct 25, 2038

    granted

  17. US 10113183

    Adeno-associated virus vectors for treatment of glycogen storage disease

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 30, 2018 · Expires Oct 25, 2038

    granted

  18. US 10111865

    Methods of sedation during critical care treatment

    OVID THERAPEUTICS INC. · Granted Oct 30, 2018 · Expires Oct 25, 2038

    granted

  19. US 10105344

    Methods of reducing blood lactate concentration

    Stokely-Van Camp, Inc. · Granted Oct 23, 2018 · Expires Oct 18, 2038

    granted

  20. US 10105369

    Therapeutically active compounds and their methods of use

    Agios Pharmaceuticals, Inc. · Granted Oct 23, 2018 · Expires Oct 18, 2038

    granted

  21. US 10105414

    Peptides derived from RS1 which down-regulate glucose absorption after a glucose rich meal and increase insulin sensitivity

    Julius-Maximilians-Universitat Wurzburg · Granted Oct 23, 2018 · Expires Oct 18, 2038

    granted

  22. US 10105366

    Selective calcium channel antagonists

    Northwestern University · Granted Oct 23, 2018 · Expires Oct 18, 2038

    granted

  23. US 10105289

    Biomimetic mineral based endodontic cement composition and uses thereof

    Essential Dental Systems, Inc. · Granted Oct 23, 2018 · Expires Oct 18, 2038

    granted

  24. US 10106792

    Methods and compositions for the specific inhibition of gene expression by double-stranded RNA

    INTEGRATED DNA TECHNOLOGIES, INC. · Granted Oct 23, 2018 · Expires Oct 18, 2038

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.